✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Tripeptide Research Compound
KPV Capsules are a solid-dose research format designed for studying KPV’s activity in controlled laboratory and model-system settings. Investigations typically examine its effects on inflammatory pathways and cellular response mechanisms when delivered in a standardized capsule form for experimental comparison.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
KPV is a synthetic tripeptide composed of lysine–proline–valine and is derived from the C-terminal fragment of alpha-melanocyte–stimulating hormone (α-MSH). It is developed for controlled laboratory research involving peptide-mediated signaling systems.
In scientific literature, KPV is studied in experimental models examining inflammatory pathway regulation, cytokine-associated signaling frameworks, and epithelial barrier research under in vitro and preclinical conditions.
Third-party tested for purity, identity, quantity.
KPV is evaluated in research focused on peptide-mediated inflammatory signaling and immune pathway interaction models. Experimental studies examine its interaction within cytokine-associated regulatory frameworks and epithelial barrier research systems under controlled laboratory environments.
Research publications have explored its role in inflammatory pathway modulation and peptide signaling characteristics within structured experimental conditions.
KPV emerged from investigations into biologically active fragments of α-MSH and related melanocortin peptides. Laboratory research expanded into studies examining its signaling behavior and interaction with inflammatory regulatory systems.
Subsequent experimental models explored its pathway-level activity in immune signaling and epithelial framework research contexts.
Laboratory investigations into KPV have focused on inflammatory signaling models and peptide-mediated regulatory systems. Research frameworks evaluate cytokine interaction dynamics, epithelial barrier signaling pathways, and immune-associated regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each capsule contains the labeled quantity of KPV. Independent third-party testing verifies purity, identity, and batch specifications prior to release.
The product is supplied in capsule form for laboratory research purposes. No additional materials are included.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis.
PubMedDrug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
PubMedPepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
